Cytomegalovirus vaccine in renal transplant candidates: progress report of a randomized, placebo-controlled, double-blind trial.
D000328:Adult; D000914:Antibodies, Viral / Q000276:immunology; D002648:Child; D002986:Clinical Trials as Topic; D003524:Cyclosporins / Q000627:therapeutic use; D003587:Cytomegalovirus / Q000276:immunology*; D003586:Cytomegalovirus Infections / Q000276:immunology / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation; D008297:Male; D011183:Postoperative Complications / Q000517:prevention & control; D011897:Random Allocation; D014611:Vaccination; D014613:Vaccines, Attenuated / Q000008:administration & dosage / Q000009:adverse effects; D014765:Viral Vaccines / Q000008:administration & dosage* / Q000009:adverse effects
D000914:Antibodies, Viral; D003524:Cyclosporins; D014613:Vaccines, Attenuated; D014765:Viral Vaccines